177 related articles for article (PubMed ID: 28479381)
1. Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors.
Zhou H; Chen Q; Tan W; Qiu Z; Li S; Song Y; Gao S
Gene; 2017 Aug; 625():72-77. PubMed ID: 28479381
[TBL] [Abstract][Full Text] [Related]
2. Integrative microRNA-mRNA and protein-protein interaction analysis in pancreatic neuroendocrine tumors.
Zhou HQ; Chen QC; Qiu ZT; Tan WL; Mo CQ; Gao SW
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2842-52. PubMed ID: 27424984
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
[TBL] [Abstract][Full Text] [Related]
4. Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping.
Xiao Y; Xu G; Cloyd JM; Du S; Mao Y; Pawlik TM
J Gastrointest Surg; 2022 Aug; 26(8):1670-1678. PubMed ID: 35508682
[TBL] [Abstract][Full Text] [Related]
5. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract][Full Text] [Related]
6. Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis.
Lu W; Li N; Liao F
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31412643
[TBL] [Abstract][Full Text] [Related]
7. Microarray based analysis of gene expression patterns in pancreatic neuroendocrine tumors.
Wang DD; Liu ZW; Han MM; Zhu ZM; Tu YL; Dou CQ; Jin X; Cai SW; Du N
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3367-74. PubMed ID: 26439030
[TBL] [Abstract][Full Text] [Related]
8. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.
Duerr EM; Mizukami Y; Ng A; Xavier RJ; Kikuchi H; Deshpande V; Warshaw AL; Glickman J; Kulke MH; Chung DC
Endocr Relat Cancer; 2008 Mar; 15(1):243-56. PubMed ID: 18310291
[TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.
Wong HL; Yang KC; Shen Y; Zhao EY; Loree JM; Kennecke HF; Kalloger SE; Karasinska JM; Lim HJ; Mungall AJ; Feng X; Davies JM; Schrader K; Zhou C; Karsan A; Jones SJM; Laskin J; Marra MA; Schaeffer DF; Gorski SM; Renouf DJ
Cold Spring Harb Mol Case Stud; 2018 Feb; 4(1):. PubMed ID: 29092957
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis.
Wang Q; Yu C
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496505
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Immune Subtypes for the Prediction of Metastasis in Pancreatic Neuroendocrine Tumors.
Meng D; Zhao L; Liu J; Ge C; Zhang C
Neuroendocrinology; 2023; 113(7):719-735. PubMed ID: 36871552
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
15. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice.
Yu R; Dhall D; Nissen NN; Zhou C; Ren SG
PLoS One; 2011; 6(8):e23397. PubMed ID: 21853126
[TBL] [Abstract][Full Text] [Related]
17. EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.
Saller J; Seydafkan S; Shahid M; Gadara M; Cives M; Eschrich SA; Boulware D; Strosberg JR; Aejaz N; Coppola D
Cancer Genomics Proteomics; 2019; 16(5):309-318. PubMed ID: 31467225
[TBL] [Abstract][Full Text] [Related]
18. Animal models and cell lines of pancreatic neuroendocrine tumors.
Babu V; Paul N; Yu R
Pancreas; 2013 Aug; 42(6):912-23. PubMed ID: 23851429
[TBL] [Abstract][Full Text] [Related]
19. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
Bi D; Ning H; Liu S; Que X; Ding K
Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
Uemura J; Okano K; Oshima M; Suto H; Ando Y; Kumamoto K; Kadota K; Ichihara S; Kokudo Y; Maeba T; Nanno Y; Toyama H; Takada Y; Shimada M; Hanazaki K; Masaki T; Suzuki Y
Ann Surg; 2021 Dec; 274(6):e949-e956. PubMed ID: 31599805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
